Literature DB >> 13891922

Increase of blood fibrinolytic activity by testosterone.

G R FEARNLEY, R CHAKRABARTI.   

Abstract

Entities:  

Keywords:  BLOOD SUGAR/pharmacology; FIBRINOLYSIS/pharmacology; NEOPLASMS/therapy; TESTOSTERONE/therapy; VASCULAR DISEASES, PERIPHERAL/therapy

Mesh:

Substances:

Year:  1962        PMID: 13891922     DOI: 10.1016/s0140-6736(62)90009-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  THROMBOLYTIC THERAPY.

Authors:  A S DOUGLAS; G P MCNICOL
Journal:  Proc R Soc Med       Date:  1964-07

3.  THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS.

Authors:  M J TSAPOGAS
Journal:  Ann R Coll Surg Engl       Date:  1964-05       Impact factor: 1.891

4.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

5.  The smoker's paradox and the real risk of smoking.

Authors:  Friedebert Kunz; Christoph Pechlaner; Helmut Hörtnagl; Rudolf Pfister
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

6.  Fibrinolytic activity in health and vascular disease.

Authors:  T W Meade; R Chakrabarti; W R North
Journal:  Br Med J       Date:  1977-03-26

7.  Abnormalities of blood coagulation at high altitude.

Authors:  I Singh; I S Chohan
Journal:  Int J Biometeorol       Date:  1972-08       Impact factor: 3.787

8.  Blood coagulation changes at high altitude predisposing to pulmonary hypertension.

Authors:  I Singh; I S Chohan
Journal:  Br Heart J       Date:  1972-06

9.  Phenoformin as a fibrinolytic drug.

Authors:  G R Fearnley
Journal:  Postgrad Med J       Date:  1968-06       Impact factor: 2.401

10.  Mesterolone: thrombosis during treatment, and a study of its prothrombotic effects.

Authors:  G D Lowe; J E Thomson; M M Reavey; C D Forbes; C R Prentice
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.